William J. Chudd
  1. Partner

Mr. Chudd is a partner in Davis Polk’s Corporate Department and a member of the firm’s Mergers & Acquisitions and Private Equity Groups. He is also the co-head of the firm’s Private Equity Group. His diverse and broad-based practice encompasses mergers and acquisitions, private equity transactions, joint ventures, collaborations and other corporate partnering transactions, restructurings, spinoffs, and takeover and corporate governance matters.

He regularly represents private equity firms and their portfolio companies in all aspects of their businesses, including acquisitions and dispositions of public and private companies, recapitalizations, minority investments, co-investment arrangements, and formation of private equity funds. His clients include Atairos, Bansk Group, Cerberus, Cornell Capital and Tailwind Capital.

Mr. Chudd also has extensive experience advising multinational corporations on their most critical business initiatives and transactions, including both domestic and cross-border M&A transactions. He has handled matters across many industries, with experience in energy, healthcare, asset management, consumer products, defense, financial services, logistics/transportation services, technology, retail, media and business services sectors.

Work Highlights

Public Company and Take Private Transactions

  • Acquisition of Shire by Takeda, and proposed acquisition by AbbVie
  • Shire acquisitions of NPS Pharma and ViroPharma
  • ExxonMobil acquisitions of InterOil and XTO Energy
  • Comcast proposed acquisition of Time Warner Cable
  • MSCI acquisition of RiskMetrics
  • Maidenform acquisition by Hanesbrands
  • Roche going-private acquisition of Genentech
  • VF acquisition of Timberland
  • AstraZeneca acquisition of MedImmune

Healthcare and Life Sciences

  • Takeda disposition of Xiidra®
  • Shire on its:
    • acquisition by Takeda
    • sale of Oncology business
    • proposed acquisition by AbbVie
    • acquisitions of NPS Pharma, ViroPharma, Foresight, Bikam, Lumena, SARcode, Lotus Tissue Repair, FerroKin and New River Pharmaceuticals
  • Cornell Capital acquisitions of Fastaff, U.S. Nursing and trustaff
  • Roche going-private acquisition of Genentech
  • AstraZeneca acquisition of MedImmune
  • Warner Chilcott global collaboration agreement with Sanofi-Aventis

Industrials and Energy

  • ExxonMobil on a number of transactions, including acquisitions of InterOil and XTO Energy
  • Cornell Capital investments in MRC Global and Monolith Materials
  • Tailwind Capital investments in Acertus, Anvil-Smith Cooper and Trench Plate Rental

Financial Services, Insurance and Investment Advice

  • MSCI acquisitions of Insignis, IPD Group and RiskMetrics, and disposition of ISS
  • FRBNY and the U.S. Treasury in the recapitalization of AIG
  • PartnerRe acquisition of ParisRe

Tech, Media and Telecom

  • Cerberus strategic investment in Comscore
  • Comcast proposed acquisition of Time Warner Cable
  • Comcast investments in Clearwire Communication
  • Comcast commercial agreements with Verizon Wireless
  • Tailwind Capital investment in Material

Consumer Products and Retail

  • Bansk Group acquisition of Woodstream
  • Cornell Capital investments in Instant Brands
  • Maidenform acquisition by Hanesbrands
  • VF acquisition of Timberland


  • Lockheed Martin acquisition of Sikorsky Aircraft

Joint Ventures and Other Arrangements

  • Comcast investments in Clearwire, along with Google, Intel, and Time Warner Cable
  • Atairos in the combination of Learfield and IMG College
  • Comcast commercial agreements with Verizon Wireless
  • Warner Chilcott global collaboration agreement with Sanofi-Aventis


  • Law360 – “Rising Star: M&A,” 2014, 2016
  • Chambers USA – Corporate/M&A, New York
  • Chambers USA – "Up and Coming Individual," 2016
  • IFLR1000 – M&A, United States

Professional History

  • Partner, 2011-present
  • Associate, 2002-2011

Bar Admissions

  • State of New York


  • B.S., Cornell University, 1999
  • J.D., Cornell Law School, 2002
    • magna cum laude